Language selection

Government of Canada / Gouvernement du Canada

Search

Lot Release Program for schedule D (biologic) drugs : revised guidance document for implementation.: H164-418/2026E-PDF

"This document outlines the Lot Release Program for Schedule D (biologic) drugs. It also covers the extent of the review and testing of biologic drugs prior to their release for sale in Canada by the Biologic and Radiopharmaceutical Drugs Directorate (BRDD)"--Introduction, page 1.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.959619&sl=0

Publication information
Department/Agency
  • Canada. Health Canada, issuing body.
TitleLot Release Program for schedule D (biologic) drugs : revised guidance document for implementation.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Lignes directrices sur le Programme d'autorisation de mise en circulation des lots de drogues visées à l'annexe D (produits biologiques) : lignes directrices révisées pour la mise en œuvre.
  • "Pub.: 250442."
Publishing information
  • Ottawa, ON : Health Canada = Santé Canada, April 2026.
  • ©2026
Description1 online resource (ii, 17 pages)
ISBN9780660982663
Catalogue number
  • H164-418/2026E-PDF
Departmental catalogue number250442
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: